Rang	Name	Position
1	Mr. Ofer Gonen B.Sc.	Chief Executive Officer
2	Ms. Hani Luxenburg	Chief Financial Officer
3	Dr. Shmulik Hess Ph.D.	COO & Chief Commercial Officer
4	Mr. Yaron Meyer Adv.	Executive VP, General Counsel & Corporate Secretary
5	Dr. Ety Klinger MBA, Ph.D.	Chief Medical Officer
6	Dr. Liron Gal	Vice President of Manufacturing Science & Technology
7	Mr. Barry J. Wolfenson	Executive Vice President of Strategy & Corporate Development
8	Dr. Robert J. Snyder CWS, D.P.M., F.A.C.F.A.S., FFPM, M.B.A., M.Sc.	Senior Vice President of Global Medical Affairs

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Investors Finance Co PLC	6,76%	11,43 Mio. USD
2	Yelin Lapidot Holdings Management Ltd	5,87%	9,94 Mio. USD
3	Rosalind Advisors, Inc.	5,80%	9,82 Mio. USD
4	T. Rowe Price Associates, Inc.	5,50%	9,31 Mio. USD
5	BlackRock Inc	3,45%	5,85 Mio. USD
6	Meitav Dash Investments Ltd	2,88%	4,88 Mio. USD
7	Sphera Funds Management Ltd.	2,12%	3,58 Mio. USD
8	Silverberg Bernstein Capital Management LLC	1,77%	2,99 Mio. USD
9	Point72 Asset Management, L.P.	1,36%	2,30 Mio. USD
10	UBS Group AG	1,24%	2,10 Mio. USD
11	State Street Corp	1,11%	1,89 Mio. USD
12	ARK Investment Management LLC	1,01%	1,70 Mio. USD
13	Geode Capital Management, LLC	0,94%	1,60 Mio. USD
14	Northern Trust Corp	0,94%	1,60 Mio. USD
15	Dafna Capital Management LLC	0,73%	1,24 Mio. USD
16	Morgan Stanley - Brokerage Accounts	0,69%	1,16 Mio. USD
17	Clal Insurance Enterprises Holdings Ltd	0,55%	0,93 Mio. USD
18	Sargent Investment Group, LLC	0,48%	0,82 Mio. USD
19	Citadel Advisors Llc	0,45%	0,77 Mio. USD
20	Vanguard Portfolio Management, LLC	0,45%	0,75 Mio. USD